Sun Aochuan, Liu Saiya, Yin Fen, Li Zhuangzhuang, Liu Zhengtang
Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Front Med (Lausanne). 2024 Aug 13;11:1351376. doi: 10.3389/fmed.2024.1351376. eCollection 2024.
To explore the causal relationships between 91 circulating inflammatory cytokines and sarcopenia-related traits (low hand grip strength, appendicular lean mass, and usual walking pace) by Mendelian randomized analysis.
Independent genetic variations of inflammatory cytokines and sarcopenia-related traits were selected as instrumental variables from publicly available genome-wide association studies (GWAS). The MR analysis was primarily conducted using the inverse variance-weighted (IVW) method. Sensitivity analyses included Steiger filtering and MR PRESSO, with additional assessments for heterogeneity and pleiotropy.
The IVW method indicated a causal relationship between Vascular Endothelial Growth Factor A (VEGF-A) and low hand grip strength (OR = 1.05654, 95% CI: 1.02453 to 1.08956, = 0.00046). Additionally, Tumor Necrosis Factor-beta (TNF-β) was found to have a causal relationship with appendicular lean mass (ALM) (β = 0.04255, 95% CI: 0.02838 to 0.05672, = 3.96E-09). There was no evidence suggesting a significant causal relationship between inflammatory cytokines and usual walking pace.
Our research substantiated the causal association between inflammatory cytokines, such as VEGF-A and TNF-β, and sarcopenia. This finding may provide new avenues for future clinical treatments.
通过孟德尔随机分析探讨91种循环炎症细胞因子与肌肉减少症相关特征(低握力、四肢瘦体重和通常步行速度)之间的因果关系。
从公开的全基因组关联研究(GWAS)中选择炎症细胞因子和肌肉减少症相关特征的独立遗传变异作为工具变量。主要使用逆方差加权(IVW)方法进行孟德尔随机分析。敏感性分析包括Steiger过滤和MR PRESSO,并对异质性和多效性进行额外评估。
IVW方法表明血管内皮生长因子A(VEGF-A)与低握力之间存在因果关系(OR = 1.05654,95%CI:1.02453至1.08956, = 0.00046)。此外,发现肿瘤坏死因子-β(TNF-β)与四肢瘦体重(ALM)存在因果关系(β = 0.04255,95%CI:0.02838至0.05672, = 3.96E-09)。没有证据表明炎症细胞因子与通常步行速度之间存在显著因果关系。
我们的研究证实了炎症细胞因子,如VEGF-A和TNF-β,与肌肉减少症之间的因果关联。这一发现可能为未来的临床治疗提供新途径。